While the mainstream views consider that Tau hyperphosphorylation is toxic to the affected neuron because the nature of AD brain pathology; however, reversing Tau hyperphosphorylation per se may not be sufficient to cure neurodegeneration for the reason that kinase inhibition was unable to block Tau-induced lesion. The gene discussed is MAPT; the disease is Alzheimer disease.